<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Left ventricular (LV) diastolic dysfunction is an important contributor to many different <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>LV diastolic dysfunction can manifest itself as slow LV relaxation, slow LV filling or high diastolic LV stiffness </plain></SENT>
<SENT sid="2" pm="."><plain>Diastolic abnormalities have been described in the senescent heart, in <z:hpo ids='HP_0001635'>heart failure</z:hpo> with <z:mpath ids='MPATH_458'>normal</z:mpath> ejection fraction (HFNEF), in diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, in <z:hpo ids='HP_0001650'>aortic valve stenosis</z:hpo> (AVS), in <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (HCM), as well as in <z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Fabry disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>), however, exact cellular and molecular alterations behind the diastolic deterioration in these diseases are not yet completely characterized </plain></SENT>
<SENT sid="3" pm="."><plain>Several studies thoroughly investigated altered cardiomyocyte function, changes of contractile myofilaments, extracellular collagen deposition and advanced glycation end products (AGEs) cross-linking in the background of diastolic dysfunction </plain></SENT>
<SENT sid="4" pm="."><plain>These clinical and experimental data suggest that underlying mechanisms of LV diastolic dysfunction are divergent in different cardiac pathologies, therefore the present review aims to summarize mechanisms at the cellular level of diastolic abnormalities in various <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
</text></document>